RecruitingPhase 2NCT04233749
The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans
Studying Lichen planus pigmentosus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Henry Ford Health System
- Principal Investigator
- Henry W Lim, MDHenry Ford HS
- Intervention
- Tranexamic acid tablets(drug)
- Enrollment
- 5 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2025
Study locations (1)
- New Center One, Detroit, Michigan, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04233749 on ClinicalTrials.gov